| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/03/2023 | 16:47 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse) | NASDAQ:CBLI | Cytocom Inc |
| 27/02/2023 | 12:08 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:CBLI | Cytocom Inc |
| 15/02/2023 | 15:10 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:CBLI | Cytocom Inc |
| 01/02/2023 | 22:35 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CBLI | Cytocom Inc |
| 01/02/2023 | 22:10 | Edgar (US Regulatory) | Securities Registration (section 12(g)) (8-a12g) | NASDAQ:CBLI | Cytocom Inc |
| 14/11/2022 | 23:53 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CBLI | Cytocom Inc |
| 06/10/2022 | 12:01 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CBLI | Cytocom Inc |
| 23/09/2022 | 12:02 | Edgar (US Regulatory) | Amended Current Report Filing (8-k/a) | NASDAQ:CBLI | Cytocom Inc |
| 22/03/2022 | 12:34 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:CBLI | Cytocom Inc |
| 22/03/2022 | 00:27 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CBLI | Cytocom Inc |
| 15/02/2022 | 12:46 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CBLI | Cytocom Inc |
| 30/09/2021 | 22:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CBLI | Cytocom Inc |
| 31/08/2021 | 13:32 | PR Newswire (US) | Cytocom, Inc. Announces Plan to Adopt New Corporate Name "Statera BioPharma, Inc." | NASDAQ:CBLI | Cytocom Inc |
| 16/08/2021 | 16:34 | PR Newswire (US) | Cytocom, Inc. Second Quarter 2021 Financial Results Conference Call Replay Available Via Webcast | NASDAQ:CBLI | Cytocom Inc |
| 16/08/2021 | 13:30 | PR Newswire (US) | Cytocom, Inc. Reports Second Quarter 2021 Financial Results | NASDAQ:CBLI | Cytocom Inc |
| 12/08/2021 | 22:05 | PR Newswire (US) | Cytocom, Inc. and La Jolla Institute for Immunology Announce Five-Year Research Alliance Agreement | NASDAQ:CBLI | Cytocom Inc |
| 11/08/2021 | 13:30 | PR Newswire (US) | Cytocom, Inc. Announces Participation at Liberty University's Empowering the Kingdom Through Business Conference | NASDAQ:CBLI | Cytocom Inc |
| 10/08/2021 | 13:30 | PR Newswire (US) | Cytocom, Inc. to Report Second Quarter 2021 Financial Results | NASDAQ:CBLI | Cytocom Inc |
| 09/08/2021 | 13:30 | PR Newswire (US) | Cytocom Inc. Provides Updates on Key Clinical Programs for Crohn's Disease, Hematology, Pancreatic Cancer and COVID-19 | NASDAQ:CBLI | Cytocom Inc |
| 05/08/2021 | 13:33 | PR Newswire (US) | Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs | NASDAQ:CBLI | Cytocom Inc |
| 29/07/2021 | 13:33 | PR Newswire (US) | Cytocom, Inc. Receives Commitments for $90 Million in Equity and Debt Financing | NASDAQ:CBLI | Cytocom Inc |
| 06/07/2021 | 15:16 | PR Newswire (US) | Cleveland BioLabs, Inc. and Cytocom Inc. Announce Call to Discuss Stockholder Meeting Vote Results and Proposed Merger | NASDAQ:CBLI | Cytocom Inc |
| 18/06/2021 | 00:37 | PR Newswire (US) | Cleveland BioLabs, Inc. and Cytocom Announce Registration Statement and Proxy Statement for Previously Announced Merger Decl... | NASDAQ:CBLI | Cytocom Inc |
| 11/06/2021 | 12:04 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CBLI | Cytocom Inc |
| 17/02/2021 | 22:17 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:CBLI | Cytocom Inc |
| 17/02/2021 | 22:15 | PR Newswire (US) | Cleveland BioLabs, Inc. Files Registration Statement on Form S-4 for Proposed Merger with Cytocom Inc. | NASDAQ:CBLI | Cytocom Inc |
| 22/12/2020 | 13:35 | PR Newswire (US) | Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021" | NASDAQ:CBLI | Cytocom Inc |
| 11/11/2020 | 15:11 | InvestorsHub NewsWire | Immune Therapeutics, Inc. Spinoff Cytocom, Inc. Appoints BioPharm Industry Veteran as New Chief Operating Officer | NASDAQ:CBLI | Cytocom Inc |
| 06/11/2020 | 23:02 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:CBLI | Cytocom Inc |
| 27/10/2020 | 18:14 | InvestorsHub NewsWire | Immune Therapeutics, Inc. Announces Cytocom Conference Call | NASDAQ:CBLI | Cytocom Inc |